CSI Market
Sign In | Register

Immix Biopharma Inc (IMMX) Annual Balance Sheets

Annual · GAAP · USD millions
Access IMMX quarterly Balance Sheets →
Balance sheet patterns shown here provide context for understanding Immix Biopharma Inc's financial stability and long-term positioning.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent93.93
Short-term Investments, Total6.48
Cash & Short-term Investments99.00
Other Current Assets0.00
Prepaid Expense And Other Assets Current0.83
Total Current Assets101.24
Equipment/Property/Plant Net2.52
Income Taxes Receivable PR0.00
Deferred Costs, Noncurrent AS0.09
Other Assets, Noncurrent0.99
Operating Lease Right Of Use Asset0.97
Total Assets104.84
Liabilities
Accounts Payable and Accrued Liabilities, Current LI9.97
Interest Payable, Current IN0.00
Notes Payable, Current NO0.00
Other Liabilities, Current0.14
Total Current Liabilities10.11
Total Long-term Debt0.00
Other liabilities, Noncurrent0.93
OperatingLeaseLiabilityNoncurrent0.93
Operating Lease Liability Current0.14
Total Liabilities11.04
Stockholders' Equity
Treasury Stock Common Value-0.10
Common Stock Value0.01
Treasury Stock Value0.00
Additional Paid In Capital Common Stock198.29
Retained Earnings / Accumulated Deficit-104.46
Other Equity0.06
Common Stockholder's Equity93.80
Non-controlling interests & other0.00
Total Stockholder's Equity93.80
Liabilities & Stockholder's Equity104.84
4 historic quarters locked

Sign in to unlock the full Immix Biopharma Inc balance sheet history.

Sign In Create Free Account

About Immix Biopharma Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: March 25, 2026
  • Source: form10-k.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001493152-26-012714

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License